Education: Faculty of Pharmacy, Medical University, Lublin, Poland; Master’s degree (highest honor); Doctoral thesis in pharmacology (highest honor), Department of Pharmacodynamics; Habilitation thesis in Pharmacology (highest honor), idem; since 2010–Full Professor degree, now: the Head of the Chair and Department of Pharmacology and Pharmacodynamics; 2012-2021 – Vice-Dean, 2021-2024– Dean of the Faculty of Pharmacy, Medical University of Lublin, Poland. Author of 417 papers, if=325 and a patent; tutor of 15 doctoral thesis, citation index=32. Member of numerous scientific societies, incl. the Committee of Physiological and Pharmacological Sciences of the Polish Academy of Sciences, member of the Editorial boards of 25 foreign journals, incl. Neurochemical Research and Molecules; award-winning, incl. three times with the awards of the Minister of Health and the Jędrzej Śniadecki price of the Polish Academy of Science (in 2019), Golden Medal for Long Service, Honorary Medal of Merit for Healthcare, Bronze and Silver Cross of Merit, Medal of the Medical University of Lublin, place on the TOP 2% list in the ranking World's TOP 2% Scientists containing the names of researchers whose publications are the most cited organized by Stanford University, USA in (three times; 2021-2023). Principle investigator of projects financed from external sources (i.e., NCN Opus) and EU projects, incl. High Quality Medical Education (2019-2023), NAWA Polonium (international polish-french grant, twice, now: 2024-25) and an international grant from the Visegrad Founds (2022-23). In the years 1991-2010, numerous (7 in total) research fellowships in France (INSERM grants and the Ministry of Higher Education and Research (MESR) and 11 stays at European universities under the Erasmus + program. National and foreign expert of many organizations. Invited lectures and in plenary sessions, also in French and English. Languages: Polish: native; French: fluently; English, Russian. Research subjects: psychopharmacology, pharmacotherapy, experimental pharmacology. Significant scientific, didactic and organizational experience in experimental pharmacology, neuropsychopharmacology, pharmacotherapy and neurobiology, especially in the context of research on the central nervous system and neuropsychiatric disorders. Scientific works focused on behavioral studies of the role of various neurotransmitter systems in the action of addictive substances. The main topics include: central effects of psychoactive compounds and natural products, anxiety, stress, memory and learning, depression, nociception, Parkinson's and Alzheimer's disease, dementia, psychosis, rewarding drug effects, measured in behavioral paradigms, with mice, rats and zebrafish (Danio rerio); molecular mechanisms common to addiction and memory processes (e.g., the effects of the endocannabinoid and cholinergic systems, calcium homeostasis and kinase/phosphatase balance, chronic stress) and neuropsychiatric disorders and further pharmacotherapy strategies; pharmacological screening of newly synthesized compounds and natural products isolated from plants.

Prof. Yehuda Shoenfeld is the founder and head of the Zabludowicz Center for Autoimmune Diseases, at the Sheba Medical Center, which is affiliated to the Sackler Faculty of Medicine in Tel-Aviv University in Israel. Professor Shoenfeld’s clinical and scientific works focus on autoimmune and rheumatic diseases, and he has published more than 1750 papers in journals such as New Eng J Med, Nature, The Lancet, Proc Nat Acad Scie, J Clin Invest, J Immunol, Blood, FASEB, J Exp Med, Circulation, Cancer and others. Professor Shoenfeld is on the editorial boards of 43 journals in the fields of rheumatology and autoimmunity and is the founder and the editor of the IMAJ (Israel Medical Association Journal), the representative journal of science and medicine in the English language in Israel, and also is the founder and Editor of Autoimmunity Reviews (Elsevier) (Impact factor 7.9) and co-Editor of the Journal of Autoimmunity (Impact factor 8). For the past twenty years Yehuda has been the Editor of “Harefuah” – The Israel Journal in Medicine (Hebrew). Professor Shoenfeld received the EULAR prize in 2005, in Vienna, Austria. In UC Davis, USA, Professor Shoenfeld received the Nelson’s Prize for Humanity and Science for 2008. He was recently awarded a Life Contribution Prize in Internal Medicine in Israel, 2012 as well as the ACR Master Award in 2013.

Dr. Pedro A. Jose is Professor of Medicine, University of Maryland School of Medicine, Adjunct Professor of Biochemistry and Molecular & Cellular Biology, Georgetown University School of Medicine and Visiting Professor, Third Military Medical University of the People’s Republic of China, Chongqing, P.R. China and Anhui Institute of Cardiovascular Disease, Anhui Provincial Hospital, Anhui, P.R. China. He has been invited as a guest lecturer in several universities in Australia, China, France, Germany, Ireland, Japan, Portugal, Sweden, Philippines, and USA and plenary speaker in several international meetings of learned societies. Dr. Jose received his MD degree, magna cum laude, meritissimus, from the University of Santo Tomas, Philippines, and placed first in the Philippine National Board Examinations in Medicine and Surgery. He received his PhD degree in Physiology from Georgetown University, Washington, DC and defended his dissertation with distinction. He is certified by the American Board of Pediatrics, American Sub-Board of Pediatric Nephrology, and American Society of Hypertension. He was President of the American Society of Pediatric Nephrology. Dr. Jose has chaired and continues to chair Study Sections and Emphasis Panels of the US National Institutes of Health and voluntary organizations, such as the American Heart Association and National Kidney Foundation. He reviews grant applications in foreign countries, including Italy and the Czech Republic. Dr. Jose has extensive experience in basic and translational research. The primary goal of Dr. Jose’s research is to determine the genetic bases of human essential hypertension. He has published over 340 scientific articles in prestigious journals and books including Circulation Research, Hypertension, Journal of the American Society of Nephrology, Journal of Clinical Investigation, Nature Genetics, and Proceedings of the National Academy of Sciences. His publications are cited more than 7,800 times with 41 cited more than 50 times, 17 of which are cited more than 100 times; four are covers of scientific journals and six are the subject of editorial commentaries. Dr. Jose has received several academic awards, including the 2003 Lewis K. Dahl Memorial Lecture (Council for High Blood Pressure Research, American Heart Association), 2007 Ernest H. Starling Distinguished Lecture (American Physiological Society Water and Electrolyte Homeostasis Section) and a 2007 MERIT award from the National Institutes of Health. He is a fellow of the Council for High Blood Pressure Research, American Heart Association. A key finding of Dr. Jose’s research is the demonstration of the crucial role of variants of a gene “G protein-coupled receptor kinase type 4 or GRK4” in the pathogenesis of high blood pressure in humans. Dr. Jose also showed that variations of GRK4 are very important in predisposing an individual to develop salt-sensitive high blood pressure. These studies have resulted in a patent in the US (# 6,660,474) and Japan (#4652566), patent-pending in Europe and Australia) and a provisional patent on “Compositions and Methods for Identifying and Diagnosing Salt Sensitivity of Blood Pressure” (US Provisional Patent Application #61,636,576).Variants of GRK4 may also predict the response to anti-hypertensive drugs, an example of pharmacogenomics. Four of his National Institutes of Health research grant applications received perfect scores of 10 (Project 3 of 5P01HL074940 [2009], Project 4 of 5P01HL068686 [2012], HL092196 [2013], and R01DK039308 [2011]). Dr. Jose’s research is currently funded by three R01 grants in which he is the principal investigator, two P01 grants in which he is the director of program projects, and one grant from pharma. Deciphering the role of GRK4 gene variants, in the pathogenesis of human essential hypertension, was the second advance and discovery cited by the Director of NHLBI for its FY 2004 Budget Justification to the US Congress.

Dr. Yong-Xiao Wang has been a Full Professor in Department of Molecular and Cellular Physiology at Albany Medical College since 2006. Dr. Wang obtained his MD at Wannan Medical University, PhD at Fourth Military Medical University, and postdoctoral training at Technology University of Munich and University of Pennsylvania. He has made many important findings using complementary molecular, biochemical, physiological, and genetic approaches at the molecular, organelle, cellular, tissue and organism levels in animals and human samples, had numerous publications in Nature Commun (impact factor: 14.290), Antioxid Redox Signal (8.209), Proc Natl Acad Sci USA (9.432), Nature (34.480), Circ Res (9.214), and other highly peer-reviewed journals and academic books, and served as the editorial board member and/or section editor as well as the executive committee member and/or subcommittee chair for professional societies.

Dr Fusco completed her PhD in Applied Biology and Experimental Medicine by University of Messina and Yale University School of Medicine. She worked as researcher for studies on biochemical activities (in vitro primary cultures and in vivo experimental models) for the Epitech Group, biological company. Now she is an Assistant Professor of Biochemistry at the Chemical, Biological, Pharmaceutical and Enviromental Science Department of the University of Messina, Italy. Dr Fusco has a long-lasting expertise in the induction and management of in vitro and in vivo models of inflammation and oxidative stress, which is documented by more than 100 papers published on international refereed journals. Her areas of scientific interest are the role of oxidative stress in autoimmunity, inflammation and neurodegenerative disorders; nutritional antioxidants and modulation of signal pathway.

Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, a General Practitioner, Parenteral and Enteral Medical Nutrition Therapist, Acupuncture, Pain Management and Homeopathy. Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through the teachings of Traditional Chinese Medicine and Hippocrates. Author of the theory Constitutional Homeopathy of the Five Elements Based on Traditional Chinese Medicine. Author of more than 230 publications about treatment of variety of diseases rebalancing the internal energy.